- Home
- INM vs FCNCO Comparison
INM vs FCNCO Comparison
Compare INM & FCNCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- FCNCO
- Stock Information
- Founded
- INM 1981
- FCNCO 1898
- Country
- INM Canada
- FCNCO United States
- Employees
- INM N/A
- FCNCO N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- FCNCO Major Banks
- Sector
- INM Health Care
- FCNCO Finance
- Exchange
- INM Nasdaq
- FCNCO Nasdaq
- Market Cap
- INM 5.0M
- FCNCO N/A
- IPO Year
- INM N/A
- FCNCO N/A
- Fundamental
- Price
- INM $2.10
- FCNCO $22.65
- Analyst Decision
- INM
- FCNCO
- Analyst Count
- INM 0
- FCNCO 0
- Target Price
- INM N/A
- FCNCO N/A
- AVG Volume (30 Days)
- INM 110.3K
- FCNCO 23.7K
- Earning Date
- INM 11-13-2025
- FCNCO 10-23-2025
- Dividend Yield
- INM N/A
- FCNCO 6.19%
- EPS Growth
- INM N/A
- FCNCO N/A
- EPS
- INM N/A
- FCNCO 169.70
- Revenue
- INM $4,942,633.00
- FCNCO $8,984,000,000.00
- Revenue This Year
- INM N/A
- FCNCO $0.56
- Revenue Next Year
- INM N/A
- FCNCO $2.24
- P/E Ratio
- INM N/A
- FCNCO $9.58
- Revenue Growth
- INM 7.50
- FCNCO N/A
- 52 Week Low
- INM $1.72
- FCNCO $20.57
- 52 Week High
- INM $8.27
- FCNCO $24.49
- Technical
- Relative Strength Index (RSI)
- INM 43.44
- FCNCO 52.29
- Support Level
- INM $2.04
- FCNCO $22.56
- Resistance Level
- INM $2.26
- FCNCO $22.79
- Average True Range (ATR)
- INM 0.13
- FCNCO 0.20
- MACD
- INM -0.01
- FCNCO 0.04
- Stochastic Oscillator
- INM 13.05
- FCNCO 71.64
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About FCNCO First Citizens BancShares Inc. 5.625% Non-Cumulative Perpetual Preferred Stock Series C
First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.